Skip To Main Content

EGFRvIII x CD3

(RG6156)

Solid Tumor

Phase I

A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma

NCT05187624